Award notice
STA R Max and Compact Max Coagulation Instruments
W81K0225FA128
Department of the Army, W40M Mrco Pacific. In-Vitro Diagnostic Substance Manufacturing.
Awarded
$664,401.68 on the award notice, September 19, 2025, contract W81K0225FA128
Get the next one like this from Department of the Army by email, the day it is posted.Find my opportunities
This one was awarded in 2025
13 like it are open now in in-vitro diagnostic substance manufacturing
- Cost Per Reportable Result Purchase of Immunohistochemistry Reagents for Laboratory Tests.
Department of Veterans Affairs, 260-Network Contract Office 20
Sources soughtNAICS 325413Anywhere in the US36C26027Q0058Closes in 12 daysNov 13 - Purchase of Rapid Syndromic Molecular Testing Reagents for Seattle VAMC
Department of Veterans Affairs, 260-Network Contract Office 20
Closes in 278 daysAug 6, 2027 - NOI - DNA Sequencing of Bone Marrow Failure Syndro
National Institutes of Health, National Institutes of Health Olao
Combined synopsis and solicitationNAICS 325413Anywhere in the US75N98027Q00027Closes tomorrowNov 2
Description
As published on SAM.gov.
On 19 September 2025, Joint Base Lewis McChord Health Contracting Branch awarded fixed price sole source delivery order Federal Supply Schedule contract 36F797-18-D0351 to Diagnostica Stago Inc.in Parsippany, NJ for coagulation instruments and the associated reagents, consumables and services for use in hemostatic testing to assess the effectiveness of anticoagulant therapy and monitor patients at risk of excessive bleeding for Madigan Army Medical Center, Tacoma WA 98431. This award was in
accordance with FAR 8.405-6(a)(1)(i)(B). IAW FAR 5.301 this serves as the award notice under Solicitation PANHCA25P0000006440 resulting in Delivery Order W81K0225FA128. The North American Industry Classification Systems (NAICS) code for this work is 325413, with business size standard of 1,250 employees. The NAICS is for In-Vitro Diagnostic Substance Manufacturing. The Product Service Code (PSC) is 6550. The resulting contract has a base period of performance of 01 October 2025- 30 September 2026 and three (3) subsequent options periods through 30 September 2029. Total contract value of base plus options is $664,401.68. See attached J&A for further information.
Attachments
Files listed on SAM.gov. The ones we hold a copy of download from here; the rest open SAM's download, which needs no account.
- 25-MRCO-P-298 FAR 8 STA R Max Coagulation_Redacted.pdf1.1 MB, September 23, 2025
The contract, on USAspending
Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.
- Recipient
- Diagnostica Stago Inc.
- UEI
- ND7MY2A4ZUE9
- CAGE
- 0TH01
- Vendor location
- Parsippany, NJ
- Contract
- W81K0225FA128 under 36F79718D0351, delivery order
- Obligated
- $166,100.42, current value $332,201, potential $664,402
- Actions
- 5 between September 19, 2025 and April 8, 2026
- Competition
- Full and Open Competition, 1 offer received
- Described as
- Sta R Max and Sta Compact Max Coagulation Instruments, Reagents, Controls, and Consumables for Cost Per Reportable Result (Cprr) in Support of the Core Laboratory, Department of Pathology at Madigan Army Medical Center on Joint Base Lewis-Mcchord.
- Match
- award number W81K0225FA128 equals the contract number; same awarding office W81K02 (high confidence)
- Record
- USAspending award page
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
September 23, 2025
Award notice, originally special notice
Awarded to Diagnostica Stago Inc. for $664,402. SAM.gov, notice 5aaea3120c5e4ce9b1b4ee7e3e2239b7
2 revisions on SAM
- September 23, 2025: publish, award notice
- September 15, 2025: publish, special notice
Points of contact
- Brittany Chartierbrittany.n.chartier.civ@health.mil